NCT01373359View on ClinicalTrials.gov

Prevention of Postpartum Haemorrhage With Sublingual Misoprostol or Oxytocin

PHASE3CompletedINTERVENTIONAL
Enrollment

652

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Misoprostol

400 µg sublingual misoprostol

DRUG

Oxytocin

10 IU IM

Trial Locations (1)

590010

Jawaharlal Nehru Medical College, Belagavi

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

Cipla Ltd.

INDUSTRY

collaborator

AstraZeneca

INDUSTRY

lead

Jawaharlal Nehru Medical College

OTHER